Fusion event
HBV-chr2 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
TTGCCCGGCAACGGCCAGGTCTGTGCCAAGTGTTTGCTGACGCAACCCCCACTGGCTGGGGCTTGGTCATGGGCCATCAGCGCATGCGTGGAACCTTTTC| |GGCTCCTCTGCCGATCCATACTGCGGAACTCCTAGCCGCTTGTTTTGCTCGCAGCAGGTCTGGAGCAAACATTATCGGGACTGATAACTCTGTTGTCCTA
End
194633265/193768541 (Hg38)
Nearest miRNA
hsa-mir-10b/Upstream/4635430; hsa-mir-1244-1/Downstream/13014693;
Upstream sequence
ATGCATATTTAATAAATAACTATGCTTATGAAACCACGTAGTATATTTAAACTGTGAAGCAACTCAAAAAAGTACTTTGCTTAAGGTGTTGTGTAGGGGG
Downstream sequence
ATGGAGGAGGAAGACAATAAGCATAGAAACAAATAATGCTATAAAGGTAAGTAGGAATACATGCCAAAAAGAAAAAATGTTTCTGTAAATGTGTGGTATT
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.